This site is intended for healthcare professionals

Novinky z letošního nejvýznamnějšího setkání onkologů 2022

CALYPSO: A three-arm randomized phase II study of durvalumab alone or with savolitinib or tremelimumab in previously treated advanced clear cell renal cancer

Thomas Powles

Barts ECMC, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom

Abstract number: #LBA4503   Authors: Thomas Powles Barts ECMC, Barts Cancer Institute, Queen Mary University of London, London, United Kingdom Thomas Powles, Maria Jose Mendez-Vidal, Alejo Rodriguez-Vida, Begoña Pérez-Valderrama, Emilio Esteban, Fiona Thistlethwaite, Poulam M. Patel, Urbano Anido Herranz, Gopalakrishnan Srinivasan, Abdel Hamid, James Larkin, Christy Ralph, Stefan N. Symeonides, Javier Puente, Ryan Hartmaier, Aleksandra...

Zpět

Cystická fibróza 1/2025

02 | 07 | 2025

Antiinfectives News 1/2025

27 | 06 | 2025

Paediatric News 1/2025

03 | 04 | 2025

Již brzy vyjde nové číslo časopisu Paediatric News.




Partneři projektu